Morocco's government has approved a draft decree to revise the pricing of medicines, both locally manufactured and imported, as part of a broader healthcare system overhaul. The decision was taken during the last Council of Government meeting, according to official sources.
The reform aims to make treatments more affordable and accessible to the population. It updates the modalities for setting drug prices, which had not been revised in recent years. The decree is expected to impact a wide range of medications, including those for chronic diseases.
This initiative aligns with Morocco's ongoing efforts to strengthen its healthcare sector, following the launch of a major social protection reform. The government has not yet disclosed specific price changes or implementation timelines.
